{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T01:32:04Z","timestamp":1789781524372,"version":"4.0.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["CHEST"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.chest.2016.03.004","type":"journal-article","created":{"date-parts":[[2016,3,18]],"date-time":"2016-03-18T03:00:38Z","timestamp":1458270038000},"page":"299-306","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":81,"title":["High Level of Chemokine CCL18 Is Associated With Pulmonary Function Deterioration, Lung Fibrosis Progression, and Reduced Survival in Systemic Sclerosis"],"prefix":"10.1016","volume":"150","author":[{"given":"Anna-Maria","family":"Hoffmann-Vold","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders Heiervang","family":"Tenn\u00f8e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torhild","family":"Garen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d8yvind","family":"Midtvedt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurelija","family":"Abraityte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trond Mogens","family":"Aal\u00f8kken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"May Britt","family":"Lund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathrine","family":"Brunborg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e5l","family":"Aukrust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thor","family":"Ueland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d8yvind","family":"Molberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.chest.2016.03.004_bib1","doi-asserted-by":"crossref","first-page":"272","DOI":"10.3389\/fimmu.2015.00272","article-title":"Pathogenesis of systemic sclerosis","volume":"6","author":"Pattanaik","year":"2015","journal-title":"Front Immunol"},{"key":"10.1016\/j.chest.2016.03.004_bib2","series-title":"EULAR Textbook on Rheumatic Diseases","first-page":"646","article-title":"Systemic sclerosis","author":"Allanore","year":"2012"},{"issue":"10","key":"10.1016\/j.chest.2016.03.004_bib3","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1136\/ard.2009.114264","article-title":"Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database","volume":"69","author":"Tyndall","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.chest.2016.03.004_bib4","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.semarthrit.2014.05.010","article-title":"Mortality and survival in systemic sclerosis: systematic review and meta-analysis","volume":"44","author":"Rubio-Rivas","year":"2014","journal-title":"Semin Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.chest.2016.03.004_bib5","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.3899\/jrheum.121390","article-title":"Survival and causes of death in an unselected and complete cohort of Norwegian patients with systemic sclerosis","volume":"40","author":"Hoffmann-Vold","year":"2013","journal-title":"J\u00a0Rheumatol"},{"issue":"2","key":"10.1016\/j.chest.2016.03.004_bib6","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1055\/s-0034-1371541","article-title":"Interstitial lung disease in systemic sclerosis","volume":"35","author":"Wells","year":"2014","journal-title":"Semin Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.chest.2016.03.004_bib7","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/art.22099","article-title":"Scleroderma lung: initial forced vital capacity as predictor of pulmonary function decline","volume":"55","author":"Plastiras","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.chest.2016.03.004_bib8","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1002\/art.39166","article-title":"Predictive value of serial high-resolution computed tomography analyses and concurrent lung function tests in systemic sclerosis","volume":"67","author":"Hoffmann-Vold","year":"2015","journal-title":"Arthritis Rheumatol"},{"issue":"5","key":"10.1016\/j.chest.2016.03.004_bib9","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1056\/NEJMoa1114576","article-title":"Proteome-wide analysis and CXCL4 as a biomarker in systemic sclerosis","volume":"370","author":"van Bon","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.chest.2016.03.004_bib10","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1183\/09031936.00004711","article-title":"Serum CC chemokine ligand-18 predicts lung disease worsening in systemic sclerosis","volume":"38","author":"Tiev","year":"2011","journal-title":"Eur Respir J"},{"issue":"9","key":"10.1016\/j.chest.2016.03.004_bib11","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1002\/art.21257","article-title":"Serum pulmonary and activation-regulated chemokine\/CCL18 levels in patients with systemic sclerosis: a sensitive indicator of active pulmonary fibrosis","volume":"52","author":"Kodera","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.chest.2016.03.004_bib12","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.3899\/jrheum.120997","article-title":"Can serum surfactant protein D or CC-chemokine ligand 18 predict outcome of interstitial lung disease in patients with early systemic sclerosis?","volume":"40","author":"Elhaj","year":"2013","journal-title":"J\u00a0Rheumatol"},{"issue":"5","key":"10.1016\/j.chest.2016.03.004_bib13","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1183\/09031936.00131713","article-title":"Serum CCL18 is predictive for lung disease progression and mortality in systemic sclerosis","volume":"43","author":"Schupp","year":"2014","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.chest.2016.03.004_bib14","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1189\/jlb.1204712","article-title":"Involvement of CC chemokine ligand 18 (CCL18) in normal and pathological processes","volume":"78","author":"Schutyser","year":"2005","journal-title":"J\u00a0Leukoc Biol"},{"issue":"1","key":"10.1016\/j.chest.2016.03.004_bib15","doi-asserted-by":"crossref","first-page":"128","DOI":"10.4049\/jimmunol.1003616","article-title":"Pulmonary CCL18 recruits human regulatory T\u00a0cells","volume":"189","author":"Chenivesse","year":"2012","journal-title":"J\u00a0Immunol"},{"issue":"10","key":"10.1016\/j.chest.2016.03.004_bib16","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1084\/jem.20130240","article-title":"Identification of human CCR8 as a CCL18 receptor","volume":"210","author":"Islam","year":"2013","journal-title":"J\u00a0Exp Med"},{"issue":"1","key":"10.1016\/j.chest.2016.03.004_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/pr.113.007724","article-title":"International Union of Basic and Clinical Pharmacology. [corrected]. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors","volume":"66","author":"Bachelerie","year":"2013","journal-title":"Pharmacol Rev"},{"issue":"7","key":"10.1016\/j.chest.2016.03.004_bib18","doi-asserted-by":"crossref","DOI":"10.1111\/cea.12065","article-title":"Role of CCL18 in asthma and lung immunity","volume":"43","author":"Tsicopoulos","year":"2013","journal-title":"Clin Exp Allergy"},{"issue":"2","key":"10.1016\/j.chest.2016.03.004_bib19","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1016\/j.atherosclerosis.2008.10.010","article-title":"Expression of chemokine (C-C motif) ligand 18 in human macrophages and atherosclerotic plaques","volume":"204","author":"H\u00e4gg","year":"2009","journal-title":"Atherosclerosis"},{"issue":"4","key":"10.1016\/j.chest.2016.03.004_bib20","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.ccr.2011.02.006","article-title":"CCL18 from tumor-associated macrophages promotes breast cancer metastasis via PITPNM3","volume":"19","author":"Chen","year":"2011","journal-title":"Cancer Cell"},{"issue":"8","key":"10.1016\/j.chest.2016.03.004_bib21","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1164\/rccm.200808-1201OC","article-title":"Serum CC-chemokine ligand 18 concentration predicts outcome in idiopathic pulmonary fibrosis","volume":"179","author":"Prasse","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.chest.2016.03.004_bib22","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/labinvest.2010.73","article-title":"Circulating monocytes from systemic sclerosis patients with interstitial lung disease show an enhanced profibrotic phenotype","volume":"90","author":"Mathai","year":"2010","journal-title":"Lab Invest"},{"issue":"1","key":"10.1016\/j.chest.2016.03.004_bib23","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3899\/jrheum.140047","article-title":"Performance of the 2013 American College of Rheumatology\/European League Against Rheumatism Classification Criteria for Systemic Sclerosis (SSc) in large, well-defined cohorts of SSc and mixed connective tissue disease","volume":"42","author":"Hoffmann-Vold","year":"2015","journal-title":"J\u00a0Rheumatol"},{"issue":"suppl 3","key":"10.1016\/j.chest.2016.03.004_bib24","doi-asserted-by":"crossref","first-page":"A59","DOI":"10.1136\/annrheumdis-2013-eular.238","article-title":"Classification criteria for systemic sclerosis: preliminary results","volume":"72","author":"Van den Hoogen","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"10.1016\/j.chest.2016.03.004_bib25","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1093\/rheumatology\/kes076","article-title":"Prevalence of systemic sclerosis in south-east Norway","volume":"51","author":"Hoffmann-Vold","year":"2012","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"10.1016\/j.chest.2016.03.004_bib26","first-page":"202","article-title":"Scleroderma (systemic sclerosis): classification, subsets and pathogenesis","volume":"15","author":"LeRoy","year":"1988","journal-title":"J\u00a0Rheumatol"},{"issue":"20","key":"10.1016\/j.chest.2016.03.004_bib27","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1093\/eurheartj\/ehp297","volume":"30","author":"Gali\u00e8","year":"2009","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.chest.2016.03.004_bib28","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1148\/radiol.2462070712","article-title":"Fleischner Society: glossary of terms for thoracic imaging","volume":"246","author":"Hansell","year":"2008","journal-title":"Radiology"},{"issue":"suppl 16","key":"10.1016\/j.chest.2016.03.004_bib29","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1183\/09041950.005s1693","article-title":"Official Statement of the European Respiratory Society. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal","volume":"16","author":"Quanjer","year":"1993","journal-title":"Eur Respir J Suppl"},{"issue":"11","key":"10.1016\/j.chest.2016.03.004_bib30","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1164\/rccm.200706-877OC","article-title":"Interstitial lung disease in systemic sclerosis: a simple staging system","volume":"177","author":"Goh","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.chest.2016.03.004_bib31","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1165\/rcmb.2015-0012OC","article-title":"Phenotypic, functional, and plasticity features of classical and alternatively activated human macrophages","volume":"53","author":"Tarique","year":"2015","journal-title":"Am J Respir Cell Mol Biol"}],"container-title":["CHEST"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369216416429?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369216416429?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T22:57:34Z","timestamp":1762124254000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369216416429"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["S0012369216416429"],"URL":"https:\/\/doi.org\/10.1016\/j.chest.2016.03.004","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High Level of Chemokine CCL18 Is Associated With Pulmonary Function Deterioration, Lung Fibrosis Progression, and Reduced Survival in Systemic Sclerosis","name":"articletitle","label":"Article Title"},{"value":"CHEST","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chest.2016.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}